News + Filings Holdings
|
D. E. Shaw & Co., Inc.
> RVNC
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | 2,011,669 | 672,749 | 50,915,343,000 | 26,198,880,000 | $25,310.00 |
| 12/31/2022 | Revance Therapeutics, Inc. | RVNC | 1,338,920 | -130,653 | 24,716,463,000 | 24,676,785,000 | $18,460.00 |
| 09/30/2022 | Revance Therapeutics, Inc. | RVNC | 1,469,573 | 651,833 | 39,678,000 | 28,376,000 | $27.00 |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | 817,740 | -28,528 | 11,302,000 | -5,200,000 | $13.82 |
| 03/31/2022 | Revance Therapeutics, Inc. | RVNC | 846,268 | 322,350 | 16,502,000 | 7,952,000 | $19.50 |
| 12/31/2021 | Revance Therapeutics, Inc. | RVNC | 523,918 | 514,678 | 8,550,000 | 8,293,000 | $16.32 |
| 09/30/2021 | Revance Therapeutics, Inc. | RVNC | 9,240 | -38,847 | 257,000 | -1,168,000 | $27.81 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | 48,087 | 48,087 | 1,425,000 | 1,425,000 | $29.63 |
| 03/31/2021 | Revance Therapeutics, Inc. | RVNC | 0 | -8,933 | 0 | -253,000 | |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | 8,933 | -22,651 | 253,000 | -541,000 | $28.32 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | 31,584 | 20,473 | 794,000 | 523,000 | $25.14 |
| 06/30/2020 | Revance Therapeutics, Inc. | RVNC | 11,111 | -1,189 | 271,000 | 89,000 | $24.39 |
| 03/31/2020 | Revance Therapeutics, Inc. | RVNC | 12,300 | 12,300 | 182,000 | 182,000 | $14.80 |
| 09/30/2019 | Revance Therapeutics, Inc. | RVNC | 0 | -21,686 | 0 | -281,000 | |
| 06/30/2019 | Revance Therapeutics, Inc. | RVNC | 21,686 | -8,043 | 281,000 | -188,000 | $12.96 |
| 03/31/2019 | Revance Therapeutics, Inc. | RVNC | 29,729 | -70,761 | 469,000 | -1,554,000 | $15.78 |
| 12/31/2018 | Revance Therapeutics, Inc. | RVNC | 100,490 | 35,288 | 2,023,000 | 403,000 | $20.13 |
| 09/30/2018 | Revance Therapeutics, Inc. | RVNC | 65,202 | -12,792 | 1,620,000 | -521,000 | $24.85 |
| 06/30/2018 | Revance Therapeutics, Inc. | RVNC | 77,994 | 68,706 | 2,141,000 | 1,855,000 | $27.45 |
| 03/31/2018 | Revance Therapeutics, Inc. | RVNC | 9,288 | -34,884 | 286,000 | -1,293,000 | $30.79 |
| 12/31/2017 | Revance Therapeutics, Inc. | RVNC | 44,172 | 44,172 | 1,579,000 | 1,579,000 | $35.75 |
| 03/31/2017 | Revance Therapeutics, Inc. | RVNC | 0 | -10,717 | 0 | -222,000 | |
| 12/31/2016 | Revance Therapeutics, Inc. | RVNC | 10,717 | 10,717 | 222,000 | 222,000 | $20.71 |
| 06/30/2016 | Revance Therapeutics, Inc. | RVNC | 0 | -54,621 | 0 | -954,000 | |
| 03/31/2016 | Revance Therapeutics, Inc. | RVNC | 54,621 | -105,318 | 954,000 | -4,510,000 | $17.47 |
| 12/31/2015 | Revance Therapeutics, Inc. | RVNC | 159,939 | 159,939 | 5,464,000 | 5,464,000 | $34.16 |
| 09/30/2015 | Revance Therapeutics, Inc. | RVNC | 25,400 | 25,400 | 756,000 | 756,000 | $29.76 |
| 06/30/2015 | Revance Therapeutics, Inc. | RVNC | 41,772 | 41,772 | 1,336,000 | 1,336,000 | $31.98 |
| << Prev Next >> |
|